Blog Posts

Wafik El-Deiry: Are We Ready to Reduce Animal Testing in Cancer Drug Development

Wafik S. El-Deiry/brown.edu

Jul 9, 2025, 17:21

Wafik El-Deiry: Are We Ready to Reduce Animal Testing in Cancer Drug Development

Wafik El-Deiry, Chair at WIN Consortium in Cancer Personalized Medicine, shared on LinkedIn:

“Are we ready to reduce animal testing in cancer drug development and to require alternatives in each new NIH grant submission?”

More posts featuring Wafik El-Deiry.

cancer drug development NIH OncoDaily Oncology Wafik El-Deiry Wafik S. El-Deiry

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Voices

Aug 21, 2025, 14:21

Caryn Lerman: HPV16 Causes More Than Half of Cervical Cancer Cases

Voices

Aug 21, 2025, 14:18

Svetlana Nikic: Changing the Game in Precision Oncology Education

Voices

Aug 21, 2025, 14:07

NCI Awards $4.5M to Myosin Therapeutics for Groundbreaking Glioblastoma Clinical Trial

Voices

Aug 21, 2025, 14:06

Krishna Soujanya Gunturu: The Hartford HealthCare Cancer Institute is Expanding its Clinical Research Team

Voices

Aug 21, 2025, 14:01

IU Simon Cancer Center Engages 1,800 Fairgoers at Indiana State Fair

Voices

Aug 21, 2025, 13:39

Boston City Councilor Visited Dana-Farber to Learn About EQUAL Study

Voices

Aug 21, 2025, 13:35

David Skorton: $2 Billion Loss - NIH Funding Crisis Hits Clinical Trials

Insight

Aug 21, 2025, 13:21

Harpreet Singh: FDA’s New Draft Guidance on Radiopharmaceutical Dosing Is Here

Voices

Aug 21, 2025, 13:19

Miriam Mutebi: Why We Need to Expand Research in Palliative and Supportive Care

Insight

Aug 21, 2025, 13:16

Javier Martin-Broto: Collaborative Study Supports Mifamurtide Use in Osteosarcoma Treatment

Voices

Aug 21, 2025, 12:57

How Cancer-Induced Nerve Injury Contributes to Immunotherapy Resistance - MD Anderson Cancer Center

Voices

Aug 21, 2025, 12:34

Nirmala Bhoo Pathy: First-Ever Workshop on Patient and Financial Navigation